Gossamer Bio, Inc. Contracts & Agreements
55 Contracts & Agreements
- Business Finance (18 contracts)
- Business Operations (1)
- Human Resources (23)
- Intellectual Property (3)
- Real Estate (3)
- Uncategorized (7)
- Gossamer Bio, Inc. Non-Employee Director Compensation Program (Filed With SEC on March 5, 2024)
- Employment Letter, dated November 25, 2023, by and between Robert Smith and the Registrant (Filed With SEC on March 5, 2024)
- Gossamer Bio, Inc. 2023 Employment Inducement Incentive Award Plan and Form of Stock Option Agreement thereunder (Filed With SEC on November 27, 2023)
- Form of Option Repricing and Cancellation Agreement (Filed With SEC on August 8, 2023)
- Form of Warrant (Filed With SEC on July 20, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on July 20, 2023)
- Gossamer Bio, Inc. Non-Employee Director Compensation Program (Filed With SEC on March 17, 2023)
- Third Amendment to Credit, Guarant (Filed With SEC on March 17, 2023)
- Fourth Amendment to Credit, Guarantee and Security Agreement, dated February 14, 2023, by and among the Registrant, GB001, Inc., GB002, Inc. and GB004, Inc., as co-borrowers, the... (Filed With SEC on March 17, 2023)
- Second Amendment to Sublease Agreement, dated June 1, 2022, by and between The Medicines Company and the Registrant (Filed With SEC on August 9, 2022)
- Stock Purchase Agreement, dated July 12, 2022, by and among the Company and the Purchasers named therein (Filed With SEC on July 13, 2022)
- Gossamer Bio, Inc. Non-Employee Director Compensation Program (Filed With SEC on March 3, 2022)
- Employment Letter, dated April 16, 2021, by and between Caryn Peterson and the Registrant (Filed With SEC on August 9, 2021)
- Employment Letter, dated May 1, 2021, by and between Laura Carter and the Registrant (Filed With SEC on August 9, 2021)
- Employment Letter, dated June 21, 2021, by and between Richard Aranda and the Registrant (Filed With SEC on August 9, 2021)
- Gossamer Bio, Inc. Non-Em (Filed With SEC on May 6, 2021)
- Description of Securities Registered under Section 12 of the Exchange Act (Filed With SEC on February 26, 2021)
- Transition Agreement, dated November 17, 2020, by and between Sheila Gujrathi, M.D. and the Registrant (Filed With SEC on February 26, 2021)
- Letter Agreement, dated November 16, 2020, by and between Faheem Hasnain and the Registrant (Filed With SEC on February 26, 2021)
- Amendment No. 1 to License Agreement, dated May 11, 2020, by and between GB004, Inc. and Aerpio Pharmaceuticals, Inc (Filed With SEC on August 11, 2020)
- Second Amendment to Credit, Guaranty and Security Agreement by and among Gossamer Bio, Inc., GB001, Inc., GB002, Inc. and GB004, Inc., as co-borrowers, the other guarantors from... (Filed With SEC on July 2, 2020)
- Underwriting Agreement, dated May 18, 2020, related to the Common Stock (Filed With SEC on May 21, 2020)
- Underwriting Agreement, dated May 18, 2020, related to the Notes (Filed With SEC on May 21, 2020)
- Indenture, dated May 21, 2020 (Filed With SEC on May 21, 2020)
- Gossamer Bio, Inc. Restricted Stock Unit Agreement under the 2019 Equity Incentive Plan (Filed With SEC on May 12, 2020)
- Description of Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 24, 2020)
- First Amendment to Credit, Guaranty and Security Agreement, dated September 18, 2019, by and among GB001, Inc., as borrower, the Registrant, as guarantor, the other guarantors... (Filed With SEC on November 12, 2019)
- Letter Agreement, dated June 3, 2019, by and between Feheem Hasnain and the Registrant (Filed With SEC on August 8, 2019)
- Credit, Guaranty and Security Agreement by and among GB001, as borrower, Gossamer Bio, Inc., as guarantor, the other guarantors from time to time party thereto and MidCap... (Filed With SEC on May 3, 2019)
- Form of Underwriting Agreement (Filed With SEC on January 30, 2019)
- Form of Underwriting Agreement (Filed With SEC on January 23, 2019)
- Specimen stock certificate evidencing the shares of common stock (Filed With SEC on January 23, 2019)
- Gossamer Bio, Inc. 2019 Incentive Award Plan and form of stock option grant notice and stock option agreement thereunder (Filed With SEC on January 23, 2019)
- Gossamer Bio, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on January 23, 2019)
- Gossamer Bio, Inc. Non-Employee Director Compensation Program (Filed With SEC on January 23, 2019)
- Amended and Restated Investors Rights Agreement, dated July 20, 2018, by and among the Registrant and certain of its stockholders (Filed With SEC on December 21, 2018)
- Gossamer Bio, Inc. 2017 Equity Incentive Plan, as amended (Filed With SEC on December 21, 2018)
- Form of stock option grant notice and stock option agreement under Gossamer Bio, Inc. 2017 Equity Incentive Plan, as amended (Filed With SEC on December 21, 2018)
- Form of restricted stock grant notice and restricted stock agreement under Gossamer Bio, Inc. 2017 Equity Incentive Plan, as amended (Filed With SEC on December 21, 2018)
- Form of Founder restricted stock grant notice and restricted stock agreement (Filed With SEC on December 21, 2018)
- Gossamer Bio, Inc. 2019 Incentive Award Plan and form of stock option grant notice and stock option agreement thereunder (Filed With SEC on December 21, 2018)
- Gossamer Bio, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on December 21, 2018)
- Gossamer Bio, Inc. Non-Employee Director Compensation Program (Filed With SEC on December 21, 2018)
- Employment Letter, dated January 4, 2018, by and between Sheila Gujrathi, M.D. and the Registrant (Filed With SEC on December 21, 2018)
- Employment Letter, dated January 4, 2018, by and between Faheem Hasnain and the Registrant (Filed With SEC on December 21, 2018)
- Employment Letter, dated December 4, 2018, by and between Bryan Giraudo and the Registrant (Filed With SEC on December 21, 2018)
- Employment Letter, dated December 4, 2018, by and between Christian Waage and the Registrant (Filed With SEC on December 21, 2018)
- Employment Letter, dated December 4, 2018, by and between Jakob Dupont, M.D. and the Registrant (Filed With SEC on December 21, 2018)
- Employment Letter, dated December 4, 2018, by and between Luisa Salter-Cid, Ph.D. and the Registrant (Filed With SEC on December 21, 2018)
- Form of Indemnification Agreement (Filed With SEC on December 21, 2018)
- Sublease Agreement, dated December 29, 2017, by and between The Medicines Company and the Registrant (Filed With SEC on December 21, 2018)
- First Amendment to Sublease Agreement, dated August 24, 2018, by and between The Medicines Company and the Registrant (Filed With SEC on December 21, 2018)
- Exclusive License Agreement, dated October 2, 2017, by and between GB002, Inc., the Registrant and Pulmokine, Inc (Filed With SEC on December 21, 2018)
- License Agreement, dated June 24, 2018, by and between Aerpio Pharmaceuticals, Inc. and GB004, Inc (Filed With SEC on December 21, 2018)
- Board Designation Letter Agreement, dated July 20, 2018, between the Registrant and HH Goss Holdings LLC (Filed With SEC on December 21, 2018)
